Michael “Mike” Albert, MD ⁦‪@MichaelAlbertMD‬⁩ It has begun. Starting off with commemorating 40 years of obesity research. #OW2022 pic.twitter.com/z3cPMOxTV6 11/1/22, 11:21 AM

Joseph Thornton

	Michael Okun ⁦‪@MichaelOkun‬⁩ Acute depressive phase; ECT superior to ketamine. Ketamine however: lower risks for headache and muscle pain; ECT: lower risks blurred vision, vertigo, diplopia/nystagmus, transient dissociative/depersonalization symptoms. ja.ma/3DNO6Du 10/31/22, 10:28 PM

Joseph Thornton

https://www.nature.com/articles/s41582-022-00733-7

Joseph Thornton

	Michael Okun ⁦‪@MichaelOkun‬⁩ Can we agree tele-health for use in cognitive behavioral therapy for PD a good idea? I know debate of PD dx, however ACCESS benefits for intense therapy hard to match. New SMALL randomized pilot study positive; (depression, anxiety, apathy, QOL benefit). …mentdisorders.onlinelibrary.wiley.com/doi/epdf/10.10… pic.twitter.com/E6cuteu6Au 10/30/22, 8:04 AM

Joseph Thornton

	Laurie Garrett ⁦‪@Laurie_Garrett‬⁩ NYC’s Health Commish has #COVID19 “I am grateful that my symptoms are quite mild, which I credit to my recent booster dose. “I will be isolating at home for the #CDC -recc’ed 5-day period…After that, I will wear masks, to complete the 10-day intervl from the start of symptoms.” pic.twitter.com/XIO1dQDeMn 10/30/22, 1:40 PM

Joseph Thornton

	AMA Journal of Ethics ⁦‪@JournalofEthics‬⁩ Abigail E. Lowe, MA, Aurora B. Le, PhD, MPH, CSP, CPH, and Shawn G. Gibbs, PhD, MBA, CIH discuss how human health promotion and environmental protection sometimes complement, sometimes conflict with each other: spr.ly/6012MjkqQ 10/27/22, 8:30 AM

Joseph Thornton

https://libertystreeteconomics.newyorkfed.org/2022/10/long-covid-appears-to-have-led-to-a-surge-of-the-disabled-in-the-workplace/

Joseph Thornton

	Michael Okun ⁦‪@MichaelOkun‬⁩ If you see someone in your practice who ‘fears disease progression’ with Parkinson or other neurological diseases two learning points. 1- identify and treat anxiety proactively, 2- address and work on helping them in self efficacy. Nice read: content.iospress.com/articles/journ… 10/22/22, 10:26 AM

Joseph Thornton

	Eric Topol ⁦‪@EricTopol‬⁩ The mechanism by which time-restricted eating limits obesity (in mice) science.org/doi/10.1126/sc… ⁦‪@DamienLagarde‬⁩ ⁦‪@kazaklab‬⁩ ⁦‪@ScienceMagazine‬⁩ ⁦‪@ScienceVisuals‬⁩ re: science.org/doi/10.1126/sc… ⁦‪@JoeBass91471540‬⁩ and colleagues pic.twitter.com/iVqHsgvAy8 10/20/22, 4:02 PM

Joseph Thornton

	Michael Okun ⁦‪@MichaelOkun‬⁩ Plasma GFAP/NfL ratio promising biomarker candidate to discriminate fronto-temporal dementia subtype FTLD-tau from FTLD-TDP; may possibly classify most patients with sporadic FTLD, whose pathology cannot be determined in life. Cool new study! ja.ma/3ENaa21 pic.twitter.com/KnLUm1qeBo 10/18/22, 8:00 AM

Joseph Thornton